Shop

/Shop
  • Our Medication Errors course is an interactive course designed to provide you with the necessary skills and knowledge required to collect, assess and report medication error information in line with the recommendations from the European Medicines Agency.
  • Sale!
    The course covers the current and future requirements for the production of case narratives, at an individual level and also within regulatory submissions such as periodic benefit risk evaluation reports. Practical coaching takes place in small groups where delegates have the opportunity to discuss individual cases and receive feedback from expert tutors.
  • Sale!
    The Risk Benefit Assessment in Pharmacovigilance course enables delegates to explore the relationship between risk and benefit, plus review the integration of appropriate strategies within risk management plans.
  • Sale!
    Our interactive Pharmacovigilance Planning and Risk Management is designed for experienced staff, working in the  pharmaceutical industry (for regulatory authorities or research organisations), to critically explore existing and developing strategies to optimise risk management activities for known and potential risks of a product in its developmental stages, pre-authorisation, and for extending safety knowledge post-authorisation.
  • Sale!
    Our Introduction to Pharmacoepidemiology course is aimed at introducing delegates to the core concepts of this scientific discipline. Attendance at this course can be used as part of the training required for the Drug Safety Surveillance module of the Pharmaceutical Medicine Speciality Training (PMST).
  • Sale!
    Our EU Regulations and Guidelines for Pharmacovigilance course will cover the development and current requirements of Good Pharmacovigilance Practices (GVP). The course will also cover other aspects of the current legislation and will provide delegates with a professional working knowledge of EU Pharmacovigilance requirements and an overview of the processes and procedures necessary to ensure compliance. Consideration will also be given to the effects on pharmacovigilance requirements of the UK leaving the EU.
  • Our Monitoring Safety in Clinical Trials and Drug Development course is aimed at providing delegates with an overview of some of the challenges companies faced in implementation of safety standards and best practice in managing their implementation in order to comply with applicable legislation and guidance both pre- and post-authorisation.
  • Sale!
    The Medical Aspects of Adverse Drug Reactions course provides delegates with the opportunity to acquire concentrated instruction on the strategy of therapeutics, medical diagnosis and all medical aspects of ADRs. It is divided into individual body systems (such as hepatic, endocrine, haematological, neurological, psychiatric, cardiovascular, oncological, gastrointestinal, renal and respiratory) and general concepts of ADRs.